BeOne Medicines (NASDAQ: ONC) net income
BeOne Medicines reported a net profit of $286.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $644.8m. Its net margin was 5.4%. Earnings per share were $0.20.
Fiscal 2025 is the highest of the 10 fiscal years on record for BeOne Medicines. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $286.9m | — | 5.4% | $0.20 |
| 2024 | −$644.8m | — | −16.9% | −$0.47 |
| 2023 | −$881.7m | — | −35.9% | −$0.65 |
| 2022 | −$2,004m | — | −141.5% | −$1.49 |
| 2021 | −$1,458m | — | −123.9% | −$1.21 |
| 2020 | −$1,625m | — | −526.1% | −$1.47 |
| 2019 | −$948.6m | — | −221.5% | −$1.22 |
| 2018 | −$673.8m | — | −339.9% | — |
| 2017 | −$93.1m | — | −39.1% | — |
| 2016 | −$119.2m | — | −11,141.8% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
BeOne Medicines net income compared with its sector
By net income for its latest fiscal year, BeOne Medicines ranks 76th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of BeOne Medicines, 5.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 74th | Alnylam Pharmaceuticals | $313.7m | 8.4% |
| 75th | Aurinia Pharmaceuticals | $287.2m | 101.5% |
| 76th | BeOne Medicines | $286.9m | 5.4% |
| 77th | Innoviva | $271.2m | 65.9% |
| 78th | Chemed | $265.2m | 10.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of BeOne Medicines
- How much did BeOne Medicines earn in fiscal 2025?
- BeOne Medicines reported a net profit of $286.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $644.8m.
- What are the earnings per share of BeOne Medicines?
- They were $0.20 in fiscal 2025, compared with −$0.47 in fiscal 2024.
- What is the net margin of BeOne Medicines?
- In fiscal 2025 its net profit was 5.4% of its revenue.
- What was the most profitable year for BeOne Medicines?
- Of its last 10 fiscal years, fiscal 2025, with $286.9m.
- Where does BeOne Medicines rank in its sector by net income?
- It ranks 76th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for BeOne Medicines come from?
- From the annual report (Form 10-K) that BeOne Medicines files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that BeOne Medicines files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BeOne Medicines: the BeOne Medicines page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.